<DOC>
	<DOCNO>NCT02672436</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety ENERGI-F703 subject diabetic foot ulcer .</brief_summary>
	<brief_title>ENERGI-F703 Diabetic Foot Ulcers Phase II Study</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1 . With either gender age least 20 year old 2 . With diabetic mellitus ( DM ; currently DM medication treatment na√Øve DM subject duplicate HbA1c 6.5 % fast plasma glucose 126 mg/dL measure least one week apart Screening ) 3 . With least one cutaneous ulcer foot ( include ulcer low leg ) heal least 4 week . The large diabetic foot ulcer select target ulcer . If two ulcer large size , one bad grade select . If two ulcer large size grade , one long duration select . 4 . The target ulcer classify grade 1 3 ulcer accord Wagner Grading System ulcer size 1 cm2 50 cm2 ( Grade 3 ulcer subject may enter study debridement , abscess target ulcer control investigator 's discretion osteomyelitis present ) 5 . Subject free necrosis infection soft bone tissue ; 6 . Subject sign write informed consent form 1 . With active osteomyelitis 2 . With target ulcer size decrease least 30 % least 2 week standardofcareonly period record regular therapy Randomization visit 3 . With poor nutritional status ( albumin &lt; 2g/dl ) , poor diabetic control ( HbA1c &gt; 12 % ) , leukocyte count &lt; 2,000/mm3 , abnormal liver function ( AST , ALT &gt; 3 x upper limit normal range ) 4 . Requiring treatment systemic corticosteroid , immunosuppressive chemotherapeutic agent 5 . With know suspected hypersensitivity ingredient study product vehicle 6 . With coronary heart disease myocardial infarction , coronary artery bypass graft ( CABG ) , percutaneous transluminal coronary angioplasty ( PTCA ) within 3 month prior study 7 . Pregnant lactate premenopausal childbearing potential take reliable contraceptive method ( ) study period 8 . Enrollment investigational drug trial within 4 week enter study 9 . With condition judge investigator enter trial may detrimental subject</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Diabetic Foot Ulcer</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Wound Healing</keyword>
</DOC>